NIPH Clinical Trials Search

Improvement of cognitive function by ingestion of Phosphatidylserine containing supplement

Basic Information

Recruitment status	Pending
Health condition(s) or Problem(s) studied	Healthy adults
Date of first enrollment	2019/06/07
Target sample size	40
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	Take 3 tablets of Phosphatidylserine-containing supplement daily for 6 weeks Take 3 placebo tablets daily for 6 weeks

Outcome(s)

Primary Outcome	Evaluate cognitive function using Mini Mental State Examination (MMSE)
Secondary Outcome	Standard verbal paired-associate learning test, Benton visual retention test

Key inclusion & exclusion criteria

Age minimum	60years-old
Age maximum	Not applicable
Gender	Male and Female
Include criteria
Exclude criteria	(1)persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study (2)persons who have changed their habitats to take supplements within past 4 weeks. (3)persons who work in night shift or in day and night shift (4)persons who have been treated their illness or prevention in a clinic at their informed consent (5)persons with their medical histories as follows: serious diseases of sugar metabolism, lipid metabolism, hepatic function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system (6)persons with the medical histories of alcoholism or drug dependence (7)persons who might be developed allergic reaction to foods. (8)persons who are pregnant, breast-feeding, or hope to be pregnant during the study period (9)persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device) (10)persons who will not be judged suitable to the participants by the investigator